Pharmaceutical chief Martin Shkreli speaks on Capitol Hill in Washington, on Feb. 4, 2016, during the House Committee on Oversight and Reform Committee hearing on his former company's decision to raise the price of a lifesaving medicine. Vyera Pharmaceuticals, a company once owned by Shkreli, will pay up to $40 million to settle allegations that it jacked up the price of a life-saving medication by roughly 4 ,000% after obtaining exclusive rights to the drug. The Federal Trade Commission announced the settlement Tuesday, Dec. 7, 2021. (AP Photo/Susan Walsh, File)
Featured Photo Galleries
